Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C14H22N2O2 |
Molecular Weight | 250.3367 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
InChI
InChIKey=XSVMFMHYUFZWBK-NSHDSACASA-N
InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE SANDOZ
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EXELON (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
WHO-VATC |
QN06DA03
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE TEVA (WITHDRAWN: ALZHEIMER DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE SANDOZ (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE HEXAL (AUTHORIZED: DEMENTIA)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NIMVASTID (AUTHORIZED: ALZHEIMER DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PROMETAX (AUTHORIZED: DEMENTIA)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NIMVASTID (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
LIVERTOX |
NBK548942
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EXELON (AUTHORIZED: DEMENTIA)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE HEXAL (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
NDF-RT |
N0000000177
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
WHO-ATC |
N06DA03
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PROMETAX (AUTHORIZED: ALZHEIMER DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
NDF-RT |
N0000175723
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
NCI_THESAURUS |
C47792
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EXELON (AUTHORIZED: ALZHEIMER DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE 3M HEALTH CARE LTD (WITHDRAWN: ALZHEIMER DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NIMVASTID (AUTHORIZED: DEMENTIA)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PROMETAX (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE 1A PHARMA (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE 1 A PHARMA (AUTHORIZED: ALZHEIMER DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE 1 A PHARMA (AUTHORIZED: DEMENTIA)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE SANDOZ (AUTHORIZED: DEMENTIA)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE TEVA (WITHDRAWN: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE TEVA (WITHDRAWN: DEMENTIA)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE HEXAL (AUTHORIZED: ALZHEIMER DISEASE)
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
RIVASTIGMINE
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
PKI06M3IW0
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
7562
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
77991
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
CHEMBL636
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
123441-03-2
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
6602
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
m9639
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000089185
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
PKI06M3IW0
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
II-99
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
2392
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
1604836
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
8874
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
64358
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
183379
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB10345MIG
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
DTXSID7023564
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
DB00989
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
C072506
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY | |||
|
C66519
Created by
admin on Fri Dec 15 15:53:25 UTC 2023 , Edited by admin on Fri Dec 15 15:53:25 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)